Rare Disease Project in Russia
A multi-center rare disease Phase 3b clinical trial has been recently awarded to GCT. Managed globally by our long term Spanish CRO partner, the study will be also conducted at 2 clinical sites selected in Russia. New trial is designed to assess the safety and the efficacy of the innovative treatment for rare metabolic condition.
Picture credit: Image by Steve Buissinne from Pixabay, in public domain
Updated: February 27, 2019
Permanent link: https://2022.gctrials.com/news/rare-disease-project-in-russia/